Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Russell

Showing results (331-340 of 343) with videos related to

Pageof 35
Sort By:
Biofouling|May 24, 2013
The impact of culture medium on the development and physiology of biofilms of Pseudomonas fluorescens formed on polyurethane paintWendy J Crookes-Goodson, Caitlin L Bojanowski, Michelle L Kay, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists IIJason M Elliott, Robert W Carling, Gary G Chicchi, et al.
Journal of Medicinal Chemistry|March 4, 2005
Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunitMichael G N Russell, Robert W Carling, John R Atack, et al.
Bone Marrow Transplantation|September 15, 2015
In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?R Peffault de Latour, M Labopin, J Cornelissen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cellsThomas B Sundberg, Hwan Geun Choi, Joo-Hye Song, et al.
Bone Marrow Transplantation|August 6, 2013
Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow TransplantationJ C Marsh, R M Pearce, M B C Koh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
Predicting acute coronary events after breast cancer radiotherapy: Integrating baseline cardiovascular risk, systemic therapy, and cardiac radiation dose in the MEDIRAD BRACE studyD S Spoor, N B Boekel, F E V Leeuwen, et al.
Nature Chemical Biology|August 15, 2017
Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cellsLiv Johannessen, Thomas B Sundberg, Daniel J O'Connell, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2006
Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietyAndrew S R Jennings, Richard T Lewis, Michael G N Russell, et al.
Journal of Medicinal Chemistry|November 11, 2005
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal modelsRobert W Carling, Andrew Madin, Alec Guiblin, et al.
Pageof 35

Showing results (331-340 of 343) with videos related to

Sort By:
Pageof 35
Biofouling|May 24, 2013
The impact of culture medium on the development and physiology of biofilms of Pseudomonas fluorescens formed on polyurethane paintWendy J Crookes-Goodson, Caitlin L Bojanowski, Michelle L Kay, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists IIJason M Elliott, Robert W Carling, Gary G Chicchi, et al.
Journal of Medicinal Chemistry|March 4, 2005
Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunitMichael G N Russell, Robert W Carling, John R Atack, et al.
Bone Marrow Transplantation|September 15, 2015
In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?R Peffault de Latour, M Labopin, J Cornelissen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cellsThomas B Sundberg, Hwan Geun Choi, Joo-Hye Song, et al.
Bone Marrow Transplantation|August 6, 2013
Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow TransplantationJ C Marsh, R M Pearce, M B C Koh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
Predicting acute coronary events after breast cancer radiotherapy: Integrating baseline cardiovascular risk, systemic therapy, and cardiac radiation dose in the MEDIRAD BRACE studyD S Spoor, N B Boekel, F E V Leeuwen, et al.
Nature Chemical Biology|August 15, 2017
Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cellsLiv Johannessen, Thomas B Sundberg, Daniel J O'Connell, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2006
Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietyAndrew S R Jennings, Richard T Lewis, Michael G N Russell, et al.
Journal of Medicinal Chemistry|November 11, 2005
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal modelsRobert W Carling, Andrew Madin, Alec Guiblin, et al.
Pageof 35